Senti Biosciences is trading 8.65% down at $0.35 after closing at $0.39 on August 21, 2026, with no new company-specific announcement identified to explain the August 24 pre-market decline.
- Latest quarterly results showed a $12.75 million net loss and $17,000 in revenue, released August 14.
- Nasdaq futures are down 0.59%, while the broader market signal is mixed.